(Date:11/21/2008)...tCall/ -- Heska Corporation,(Nasdaq: HSKA ) tod...ty of,Security Analysts, 12th Annual Biotech and ...t 1177 Avenue of the Americas, 2nd Floor in New Yo... 9:35 a.m. Eastern Time (7:35 a.m.,Mountain Time)...o weeks,following the presentation through a link...
(Date:11/21/2008)...inst Lennox-Gastaut syndrome , , FRIDAY,...zel (rufinamide) has been approved as a supplement... Lennox-Gastaut syndrome, the U.S. Food and Drug A...was based on results of a four-month clinical tria... patients who took a placebo, those who took the d...
(Date:11/21/2008)...singCenter.com, the premier site,for online nursi... has been,updated to improve the interactive expe...by Lippincott Williams & Wilkins (LWW), Nursin...ontinuing education activities and free,access to... journals.,Lippincott Williams & Wilkins is a...
(Date:11/21/2008)...-FirstCall/ -- Today, prescription drugs are the f...8 percent of patients suffering chronic conditions...ic condition account for 96 percent of all prescri...costs. A proprietary new pharmacy model developed...(NYSE: MHS ) significantly reduces critical gaps...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6...n the New England Journal of Medicine suggested th...disease in some individuals. The study was conduct... who included// dentists, veterinarians, optometri... 40 to 75 years. The study focused on the relation...
...red in the clinical journal of Ophthalmology concl...with a five-year risk of ocular hypertension, and ... increased prevalence// of glaucoma, in Caucasians...ipants, aged between 43 to 84, who received baseli...
...y the Cancer and Leukemia Group B (CALGB) and pres... Symposium assessed the effectiveness of reducing ...y used chemotherapy regimen to improve survival ra...ducted as follow-up of a mathematical model which ...
...een associated to many risk factors like age, horm... alcohol consumption. Several earlier studies have... been consistent// and also because smoking often ...e not been sure that alcohol was the most importan...
Other Medicine News:Health News:Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy" 2(Date:11/19/2008)...SAND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ ...keda Oncology Company, a subsidiary of,Takeda Pha...ounced that,enrollment in the Phase 3 MONET1 tria...ith paclitaxel and carboplatin for the first-line ...(NSCLC) has been temporarily suspended,following ...
(Date:11/19/2008)...Jude scientists report basic findings on critical ...how to better treat an array of disorders , ,... -- Scientists at St. Jude Children,s Research Ho... one of the body,s enzyme workhorses called calpai...ers, calpains function in many cellular processes,...
(Date:11/19/2008)...RK, Del., Nov. 19 Isogen, a contra... sterile filling, today announced the first,phase...en was founded to,specifically address the proces...ated with the $2 billion highly-niched, low-volume...ing market segment. , Companies can invest ...
(Date:11/18/2008)...ON, November 19 NeuroDis...ervice provider and drug development Company,and...ex: 4565), a leading,international biopharmaceuti...s presenting further pivotal pre-clinical efficacy...g is a potential therapy for neuropathic pain and ...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Select Comfort Helps Families Sleep Better in Los Angeles 13410 1Select Comfort Helps Families Sleep Better in Los Angeles 13410 2Select Comfort Helps Families Sleep Better in Los Angeles 13410 3Cochlear implant recipients experience improvement in quality of life 13407 1A combination therapy of 3 vasodilators may treat portopulmonary hypertension 13404 1A combination therapy of 3 vasodilators may treat portopulmonary hypertension 13404 2Health Secretarys Statewide Tour to Discuss Health Insurance for All Pennsylvanians Makes Stop in Cambria County 13401 1Health Secretarys Statewide Tour to Discuss Health Insurance for All Pennsylvanians Makes Stop in Cambria County 13401 2... WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2007 -...otechnology company,dedicated to developing the ne...oday announced the results of a new study,indicati...may have,reduced potential for the development of ...at in laboratory assays. The study,carried out by...
... SEATTLE--(BUSINESS WIRE)--May 29, 2007 - Mitophar...he results of a research paper,where Professor Dr....isandrin B, the precursor of (-) Schisandrin B - a...ease., In a research paper entitled "SCHISANDRIN B...INJURY BY ENHANCING MYOCARDIAL,GLUTATHIONE ANTIOXI...
Other Medicine Technology:Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 2Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 3Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 2Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 3...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: